Advertisement
Rosetta Genomics (Nasdaq: ROSG), today announced it will release thirdquarter financial results on December 5, 2008, before the U.S. markets open.Rosetta Genomics will host a conference call with a simultaneous webcast todiscuss these results at 8:00 a.m. ET on Friday, December 5.
Advertisement
To access the live conference call, U.S. and Canadian participants maydial 1-866-966-5335; international participants may dial +44-20-3023-4460. Toaccess the 24-hour audio replay, U.S. and Canadian participants may dial1-866-583-1035; international participants may dial +44-20-8196-1998. Theaccess code for the replay is 181543#. The replay will be available untilDecember 12, 2008.
A live audio webcast of the call will also be available on the"Investors" section of the company's website, www.RosettaGenomics.com. Anarchived webcast will be available on the Company's website approximately twohours after the event, and will be archived for 30 days thereafter.
About Rosetta Genomics
Rosetta Genomics (Nasdaq: ROSG) is a leader in the field of microRNAs.Founded in 2000, the company's integrative research platform combiningbioinformatics and state-of-the-art laboratory processes has led to thediscovery of hundreds of biologically validated novel human microRNAs.Building on its strong IP position and proprietary platform technologies,Rosetta Genomics is working on the application of these technologies in thedevelopment of a full range of microRNA-based diagnostic and therapeutictools, focusing primarily on cancer and various women's health indications.The first microRNA diagnostic test applying Rosetta Genomics' technology hasbeen approved for clinical use by the State of New York, and the companyexpects it will be launched by licensed clinical laboratories in the UnitedStates in 2008.Contact: Media& Investors Ron Kamienchick T: +1-646-509-1893 E: [email protected]
SOURCE Rosetta Genomics Ltd
